Today, the screeners at HealthTechMovers.com picked up 2 HealthTech Stocks up over 62% past 10 days and have been added to our watchlist. These are very volatile stocks so please do your own research before you make any investments. While we list the ratings of various 3rd party services, we're not recommending these stocks and we're not paid by the featured tickers, we simply report the big movers. If the editor has a position, it will be noted below the charts.
MarketSectorMovers.com is also looking into these tickers DAWN, COGT, RMD, BSX, RACE, RTX and more.
One resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
Rhythm Pharmaceuticals, RYTM
Summary: Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company. It focused on the development and commercialization of peptide therapeutics for the treatment of rare genetic deficiencies which result in life-threatening metabolic disorders. The Company's product candidate principally consists of setmelanotide, a potent, first-in-class melanocortin-4 receptor or MC4R, agonist for the treatment of rare genetic disorders of obesity. Rhythm Pharmaceuticals, Inc. is based in Boston, MA.
Recent RYTM Stock Price (approx 10:00am EST.): $8.95
Previous Close for RYTM Stock: $8.77
Percentage Price Change Past 10 Days for RYTM stock: +94%
TipRanks.com reports that Rhythm Pharmaceuticals stock currently has 5 analysts offering 12-month price targets and the consensus is a Moderate Buy rating for RYTM stock with an average price target is $14.50.
Click here to get the full story on RYTM stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Lucira Health Inc. is a medical technology company. It is focused on the development and commercialization of transformative and infectious disease test kits. Lucira Health Inc. is based in Emeryville, California.
Recent LHDX Stock Price (approx 10:00am EST.): $3.05
Previous Close for LHDX Stock: $2.58
Percentage Price Change Past 10 Days for LHDX stock: +62%
TipRanks.com reports that Lucira Health stock currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating for LHDX stock with an average price target is $4.00.
Click here to get the full story on LHDX stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Just a reminder, one resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
The other great tool for charting is TradingView.com, so you might want to check that out too.
The information in this article was pulled from third part services. The prices listed above are not real-time and will be delayed at least 15 minutes.
MarketSectorMovers.com keeps investors informed of the top moving stocks within each sector including Health & Biotech, Technology, Energy, Metals & Mining, Financial, Consumer, Communication Services and more. We provide investors with timely information regarding top moving stocks that is sourced from our proprietary stocks screens, partner stock analysts and breaking news that identify and monitor stocks that are on the move. Join thousands of investors who already signed up for our free subscription to MarketSectorMovers.com.
